The world health and drug situation

International Journal of Risk and Safety in Medicine

Volumn 12, Issue 1, 1999, Pages 51-57

  Laing, Richard ^a  

^a BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CYTOTOXIC AGENT; ESSENTIAL DRUG; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; TUBERCULOSTATIC AGENT;

AGE DISTRIBUTION; CAUSE OF DEATH; CONFERENCE PAPER; DEMOGRAPHY; DRUG INDUSTRY; DRUG USE; HEALTH; HEALTH CARE COST; LIFE EXPECTANCY; MEDICAL PRACTICE; PHARMACY; PRESCRIPTION; QUALITY CONTROL;

EID: 0032976468     PISSN: 09246479     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. O. Abdel, The Epidemiologic transition: a theory of the epidemiology of population change, Milbank Quartely 49 (1971), 509-583.
2. R.G.A. Feacham, T. Kjellstrom, C.J.L. Murray, M. Over and M.A. Phillips, The Health of Adults in the Developing World, Oxford University Press, Oxford, 1992.
3. A. Sanchez, T.G. Ksiazek, P.E. Rollin, C.J. Peters, S.T. Nichol, A.S. Khan and B.W.J. Mahy, Reemergence of Ebola virus in Africa, EID 1(3) (July-September 1995).
4. Z. Stein and M. Susser, Editorial: AIDS - An update on the global dynamics, Am. J. Pub. Hlth. 87(6), 901-904.
5. D. Sharp, Malarial range set to spread in a warmer world, Lancet 347 (1996), 1612.
6. M.C. Raviglione, C. Dye, S. Schmidt and A. Kochim, Assessment of worldwide tuberculosis control, Lancet 350 (1997), 624-629.
7. WHO, Primary Health Care Report on the International conference on Primary Health Care, Alma Ata, Health for All, series No 1, 1978.
8. J.A. Walsh and K. Warren, Selective primary health care - An interim strategy for disease control in developing countries, NEJM 301 (1979), 967-974.
9. World Bank, Investing in Health: World Development Report 1993, Oxford University Press, Oxford, 1993.
10. WHO, The selection of essential drugs, Technical report series, 615, 1977.
11. J.D. Quick, M.L. Hume and R.W. O'Connor, eds, Managing Drug Supply Management Sciences for Health, Boston, 1981.
12. WHO, The rational use of drugs report of the conference of experts Nairobi, November 1985, published 1987.
13. J.D. Quick, J.R. Rankin, R.O. Laing, H.V. Hogerzeil, M.N.G. Dukes and A. Garnett, eds, Managing Drug Supply, 2nd edn, Kumarian Press, Hartford, USA.
14. WHO, Informed therapy, Essential Drugs Monitor No 19, 1995.
15. K. Harvey, Therapeutic guidelines - the way ahead, Essential Drugs Monitor No 19, pp. 10-11, WHO, Geneva, 1995.
16. Kit System Management in Managing Drug Supply, J.D. Quick, J.R. Rankin, R.O. Laing, H.V. Hogerzeil, M.N.G. Dukes and A. Garnett, eds, 2nd edn, Kumarian Press, Hartford, USA.
17. M. Huff-Rouselle and F. Burnett, Cost containment through pharmaceutical procurement: a Caribbean case study, Int. J. of Health Planning and Mgmt. 11 (1996), 135-157.
18. Pooled procurement through the Eastern Caribbean drug service country study 13.2, in: Managing Drug Supply, J.D. Quick, J.R. Rankin, R.O. Laing, H.V. Hogerzeil, M.N.G. Dukes and A. Garnett, eds, 2nd edn, Kumarian Press, Hartford, USA.
19. D. Broun, Procurement of pharmaceuticals in World Bank Projects HRO working papers No 38, The World Bank, 1994.
20. Management sciences for health international drug price indicator guide, Washington, DC, 1996. (Available in English, Spanish and French.)
21. WHO, How to investigate drug use in health facilities. Selected drug use indicators (WHO/DAP93.1), 1993.
22. WHO, How to investigate drug use in communities (WHO/DAP/92.3), 1992.
23. INRUD, How to use applied qualitative mehods to design drug use interventions, Working draft manual available from INRUD, Washington, DC, 1996.
24. http://www.who.it/dap-icium/index.html.
25. E. Fefer, Drug regulatory trends in Latin America. Presentation made at Latin America Health Care Congress Nassau, Bahamas, Feb. 1998.
26. S. Nightingale, International harmonization: the process as a model for government and industry collaboration, Swiss Pharma 16(12-S), 59-63.
27. Rapid examination methods against counterfeit and substandard drugs, Japan International Corporation of Welfare Services (JICWELS), Tokyo, 1997.
28. Revolving drug funds (Chapter 44), in: Managing Drug Supply, J.D. Quick, J.R. Rankin, R.O. Laing, H.V. Hogerzeil, M.N.G. Dukes and A. Garnett, eds, 2nd edn, Kumarian Press, Hartford, USA.
29. WHO, Essential Drugs, Number 23, Moves to strengthen pharmacy curricula, P14, 1997.
30. WHO, Guide to Good Prescribing (WHO/DAP/94.11), 1994.